Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials.
Torresi
Joseph
J
Department of Infectious Diseases, Austin Hospital, Heidelberg, Victoria, Australia. josepht@unimelb.edu.au
McCarthy
Karen
K
Feroldi
Emmanuel
E
Méric
Claude
C